For Quick Alerts
Subscribe Now  
Sensex Ends Lower By 465 Points; Pharma Top Laggar
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts
Read more about: stock markets pharma

Sensex Ends Lower By 465 Points; Pharma Top Laggard

|

Indian benchmark indices which started firm in today's session pared all their gains to later turn negative. Broader indices too traded with losses but outperformed the headline indices.

 

Sensex Ends Lower By 465 Points; Pharma Top Laggard

At the close, Sensex ended lower by 465 points at 48253, while Nifty ended with loss of 138 points at 14496.

Among Nifty sectoral indices towards the close of the session only Nifty PSU Bank retained its gains, which hit days' high of 2189 and gained over 6 percent. The stocks from the pack which led the gains include PNB, Bank of Baroda and SBI among others.

Heavyweights Reliance Industries as well as HDFC twins continued to drag the indices.
Gainers on the Nifty in the otherwise weak market have been SBI Life Insurance, ONGC, Bajaj finance, BPCL and Adani Ports, while laggards included Tata Consumer Products, Cipla, Dr. Reddy's Labs, Divis Lab and Sun Pharma. Pharma pack was the top laggard.

On fall in consolidated net profit, shares of L&T Technology Services tanked over 7%

Meanwhile, European indices traded mixed with DAX trading weak by up to 0.7%, while CAC and FTSE traded positive.

GoodReturns.in